Avesta Ketamine and Wellness Expands Access with New Clinic in Columbia, Maryland

Avesta Ketamine and Wellness, a prevalent name in the realm of monitored ketamine treatment, has officially opened its fourth clinic located at 5840 Banneker Road, Suite 270 in Columbia, Maryland. This move not only broadens Avesta's reach but also reinforces its mission to deliver transformative mental health and pain management solutions in a safe environment.

The new Columbia clinic joins Avesta's existing facilities in Washington, D.C., Bethesda, and McLean, Virginia, highlighting the company's commitment to providing essential care in the Washington, D.C., Maryland, and Virginia (DMV) area.

Providing Critical Services

The Columbia clinic specializes in several effective treatments for those suffering from conditions such as Treatment Resistant Depression, General Anxiety Disorder, PTSD, and Chronic Pain. Dr. Ladan Eshkevari, the co-founder and co-CEO of Avesta, shared, "Ketamine offers profound relief for people struggling with treatment-resistant depression, PTSD, anxiety, substance use disorder (SUD), and chronic pain. Too many people spend years cycling through medications and traditional therapies without improvement. With our new clinic in Columbia, we can provide more people with rapid relief in a calm, convenient, and clinically supervised setting."

This latest facility aims to cater to a community that, based on the Howard County Health Department's December 2023 report, struggles with mental health issues—where suicide is the second leading cause of death among youth aged 15-19, and a significant percentage of adults regularly grapple with poor mental health.

Personalized Treatment Plans

At Avesta, the approach to treatment is highly individualized. The clinic offers a variety of ketamine therapy protocols, including IV ketamine therapy, FDA-approved Spravato™ therapy, and ketamine-assisted psychotherapy (KAP). They work closely with customers' existing mental health professionals to tailor treatments to their unique medical histories and goals.

Deborah Tan, co-CEO of Avesta, emphasized the importance of accessibility, stating, "As part of Avesta's patient-first approach, we are committed to making ketamine therapy more accessible to Columbia area residents while simplifying the insurance process. We know that seeking ketamine therapy is a big decision, so our team works diligently to ease financial barriers to treatment, particularly for those who feel like they have run out of options."

Experienced Clinical Team

The clinic is backed by a robust clinical team led by Dr. Eshkevari, who brings over 30 years of experience in anesthesia and pain management. As a professor emeritus at Georgetown University, she has trained numerous professionals in the area and contributed to establishing ketamine protocol standards. The team includes a board-certified anesthesiologist, nurse anesthetists, and integration specialists, all focused on ensuring the safe administration of therapies while adjusting treatments as needed for optimal results.

Avesta has made significant strides in the mental health sector, having administered over 10,000 ketamine infusions over the past eight years for a range of issues such as depression, anxiety, PTSD, and chronic pain conditions.

For further details and information about services offered, interested individuals can visit www.avestaketaminewellness.com.